Get started
AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT)AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT)AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT)

AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0A4Y chart


Full chart

0A4Y upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.04 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−24.80 USD
Net income (FY)
‪−17.32 M‬ USD
Revenue (FY)
‪170.00 K‬ USD
Shares float
‪641.96 K‬
Beta (1Y)
0.91

Employees


Employees (FY)
23
Change (1Y)
−3 −11.54%
Revenue / Employee (1Y)
‪7.39 K‬ USD
Net income / Employee (1Y)
‪−753.04 K‬ USD

About AIM ImmunoTech Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Kenwood Equels
Website
aimimmuno.com
Headquarters
Ocala
Founded
1966
FIGI
BBG00XCCRNP0
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Check out other big names from the same industry as 0A4Y.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0A4Y news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0A4Y is 9.40 USD — it has increased by 8.94% in the past 24 hours. Watch AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stocks are traded under the ticker 0A4Y.
0A4Y stock has risen by 20.81% compared to the previous week, the month change is a 4.70% rise, over the last year AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) has showed a −78.58% decrease.
We've gathered analysts' opinions on AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) future price: according to them, 0A4Y price has a max estimate of 150.00 USD and a min estimate of 150.00 USD. Watch 0A4Y chart and read a more detailed AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stock forecast: see what analysts think of AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) and suggest that you do with its stocks.
0A4Y reached its all-time high on Feb 10, 2021 with the price of 304.00 USD, and its all-time low was 2.70 USD and was reached on Apr 10, 2025. View more price dynamics on 0A4Y chart.
See other stocks reaching their highest and lowest prices.
0A4Y stock is 10.37% volatile and has beta coefficient of 0.91. Track AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) there?
Today AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) has the market capitalization of ‪7.04 M‬, it has increased by 23.88% over the last week.
Yes, you can track AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) is going to release the next earnings report on Aug 19, 2025. Keep track of upcoming events with our Earnings Calendar.
0A4Y earnings for the last quarter are −8.00 USD per share, whereas the estimation was −8.00 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −8.00 USD per share. See more details about AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) earnings.
AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach ‪100.00 K‬ USD.
0A4Y net income for the last quarter is ‪−3.71 M‬ USD, while the quarter before that showed ‪−5.97 M‬ USD of net income which accounts for 37.91% change. Track more AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) financial stats to get the full picture.
No, 0A4Y doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 22, 2025, the company has 23 employees. See our rating of the largest employees — is AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) EBITDA is ‪−17.07 M‬ USD, and current EBITDA margin is ‪−11.46 K‬%. See more stats in AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) financial statements.
Like other stocks, 0A4Y shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) stock shows the neutral signal. See more of AIM IMMUNOTECH INC USD0.001 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.